Jul 06, 2017
Caribou Biosciences has appointed Steven Kanner as CSO. Kanner has more than 25 years of experience in drug discovery and development. He previously served in various research leadership roles at Bristol-Myers Squibb, Astex Pharmaceuticals, and Agensys/Astellas Pharma. Most recently, he served as vice president of discovery biology at Arrowhead Pharmaceuticals.